Here.That’s not what I read about a lot of the agreements.
-To date, the Government of Canada has allocated $1 billion for the five agreements that are in place. This includes some upfront payments that the pharmaceutical companies require to support vaccine development, testing and at-risk manufacturing.
-This investment guarantees Canada’s earliest possible place in production runs.
-Subsequent payments are contingent on the vaccines passing clinical trials and obtaining regulatory approval. All contracts Canada signs with vaccine developers contain off-ramps and exit provisions should they be required.
Last edited by a moderator: